SCIENTURE HOLDINGS, INC. Deferred Federal, State and Local, Tax Expense (Benefit)
SCIENTURE HOLDINGS, INC. (SCNX) reported Deferred Federal, State and Local, Tax Expense (Benefit) of -$1.99 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit · last filed 2026-03-30
- SCIENTURE HOLDINGS, INC. deferred federal, state and local, tax expense (benefit) for fiscal 2025 was -$1.99M.
- SCIENTURE HOLDINGS, INC. deferred federal, state and local, tax expense (benefit) for fiscal 2024 was -$534.40K.
| Period end | Deferred Federal, State and Local, Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$1.99M 10-K · filed 2026-03-30 |
| 2024-12-31 | -$534.40K 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |